US drugmakers currently have 851 medicines in development for diseases which disproportionately affect women, says a new industry report.
The products, which are all now in human clinical trials or awaiting Food and Drug Administration (FDA) review, include 139 potential treatments for cancers affecting women - 91 for breast cancer, 49 for ovarian cancer and nine for cervical cancer, says the report, from the Pharmaceutical Research and Manufacturers of America (PhRMA).
There are also 114 potential new treatments for arthritis and musculoskeletal disorders, says the group, noting that 60% of US patients with some type of arthritis or related conditions are female. 83 new treatments are in R&D for Alzheimer's disease - two-thirds of the 5.4 million Americans living with the disease are women - and 72 for depression and anxiety, which affect almost twice as many women as men....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2479